Matches in Wikidata for { <http://www.wikidata.org/entity/Q66392898> ?p ?o ?g. }
Showing items 1 to 43 of
43
with 100 items per page.
- Q66392898 description "clinical trial" @default.
- Q66392898 description "ensayu clínicu" @default.
- Q66392898 description "klinisch onderzoek" @default.
- Q66392898 description "клінічне випробування" @default.
- Q66392898 name "Seladelpar (MBX-8025) in Subjects With Primary Biliary Cholangitis (PBC)" @default.
- Q66392898 name "Seladelpar" @default.
- Q66392898 type Item @default.
- Q66392898 label "Seladelpar (MBX-8025) in Subjects With Primary Biliary Cholangitis (PBC)" @default.
- Q66392898 label "Seladelpar" @default.
- Q66392898 prefLabel "Seladelpar (MBX-8025) in Subjects With Primary Biliary Cholangitis (PBC)" @default.
- Q66392898 prefLabel "Seladelpar" @default.
- Q66392898 P1050 Q66392898-64346007-7CCA-43E0-BBE7-8664E8C11942 @default.
- Q66392898 P1132 Q66392898-82C43505-8878-446B-AC0A-A053BB182E92 @default.
- Q66392898 P1476 Q66392898-547F5130-FDD6-4B39-B520-315557BB1ED2 @default.
- Q66392898 P17 Q66392898-11706903-53A8-43EF-A627-CBC4C4514152 @default.
- Q66392898 P17 Q66392898-5AFA3400-4F33-47B3-87EA-3059084EF18B @default.
- Q66392898 P17 Q66392898-91E3D54F-AD04-4CCF-92A3-A499E87BF2B4 @default.
- Q66392898 P17 Q66392898-96232D51-F513-4DC4-A34E-BD4ACB27C5BE @default.
- Q66392898 P2899 Q66392898-E587E8D4-ADAF-4D1A-9633-24B4820C6AF9 @default.
- Q66392898 P3098 Q66392898-A1542F3B-F816-4DF8-BA68-924F1FBACAEA @default.
- Q66392898 P31 Q66392898-8D11F9F8-D78C-4687-85AE-7313EE2F5A45 @default.
- Q66392898 P4135 Q66392898-43FDCB3B-D301-4580-A544-56BA5BAC7583 @default.
- Q66392898 P4844 Q66392898-39DA8004-3933-452D-9BD5-A0B7EB54E02E @default.
- Q66392898 P580 Q66392898-2E6183FF-137D-495D-A151-63D4754CE01C @default.
- Q66392898 P582 Q66392898-AA8CE7EE-D03E-4242-B306-2C4AA08ACC47 @default.
- Q66392898 P6099 Q66392898-23E25039-FFA3-4FAD-8348-D230C3B53874 @default.
- Q66392898 P8363 Q66392898-90369289-CBB0-4502-B185-1FF60F45DDD2 @default.
- Q66392898 P1050 Q603644 @default.
- Q66392898 P1132 "+116" @default.
- Q66392898 P1476 "An 8-week, Dose Ranging, Open Label, Randomized, Phase 2 Study With a 44-week Extension, to Evaluate the Safety and Efficacy of MBX-8025 in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Response to or Intolerance to Ursodeoxycholic Acid (UDCA)" @default.
- Q66392898 P17 Q145 @default.
- Q66392898 P17 Q16 @default.
- Q66392898 P17 Q183 @default.
- Q66392898 P17 Q30 @default.
- Q66392898 P2899 "+18" @default.
- Q66392898 P3098 "NCT02955602" @default.
- Q66392898 P31 Q30612 @default.
- Q66392898 P4135 "+75" @default.
- Q66392898 P4844 Q241374 @default.
- Q66392898 P580 "2016-11-28T00:00:00Z" @default.
- Q66392898 P582 "2019-07-01T00:00:00Z" @default.
- Q66392898 P6099 Q42824440 @default.
- Q66392898 P8363 Q78089383 @default.